Amarna Therapeutics logo

Amarna Therapeutics

Next generation gene therapy | unlocking the potential & expanding the boundaries

19 employees · est. 2008 · Leiden, The Netherlands

VS
Broken String Biosciences logo

Broken String Biosciences

Turning breaks into breakthroughs

35 employees · est. 2020 · Cambridge, United Kingdom

Amarna Therapeutics is the older company (2008 vs 2020).

Side-by-Side Comparison

Amarna Therapeutics Broken String Biosciences
Founded
2008 older 2020
Headquarters
Leiden, The Netherlands Cambridge, United Kingdom
Employees
19 35
Industry
Biotechnology, Pharmaceutical Biotechnology, Health Care
Funding Stage
Grant Series A
Total Funding
$15.00M $23.65M
Funding Rounds
4 6
Services
Not tracked yet Genome-wide on- and off-target analysis, Rapid detection of gene editing-induced breaks, Support for guide screening and optimization, Integrated bioinformatics, Sequencing and data analysis
Target Customers
Not tracked yet Therapy Developers, Biotechnology Researchers, Pharmaceutical Companies, Genomics Laboratories, Regulatory Bodies
Taxonomy
Gene Therapy, Biotech, SV40, Polyoma Virus, SuperVero™, Gene Delivery, Immunogenicity, Genetic Disorders, Autoimmune Diseases, Chronic Inflammation, Research & Development, Pre-clinical, Amarna Therapeutics, Netherlands, Seville NGS-based DNA Break Mapping, Genome Stability Assessment, Cell And Gene Therapy, Off-target Genetic Edits Analysis, Gene Editing Specificity, Genetic Outcomes Evaluation, Pre-clinical Development Insights, Clinical Development Support, Innovative Medicine Development, Sequencing Tools, Data-driven Insights, Genomic Research Technology, Biotechnology Innovation, Platform Development
Website
amarnatherapeutics.com brokenstringbio.com
Amarna Therapeutics logo

About Amarna Therapeutics

Amarna Therapeutics B.V. is a pioneering biotech company based in The Netherlands, founded in 2008. The company's focus lies in the development of transformative, potentially curative gene therapies for rare and prevalent diseases. Amarna's proprietary production cell line, SuperVero™, enables the p...

Broken String Biosciences logo

About Broken String Biosciences

Broken String Biosciences, founded in 2020, is a UK-based biotechnology startup revolutionizing the cell and gene therapy landscape. Their innovative technology platform, INDUCE-seq®, aims to transform potential genetic "breaks" into groundbreaking therapies, aligning with their slogan, "Turning bre...

We will tell you when either one moves

BounceWatch watches Amarna Therapeutics and Broken String Biosciences for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Amarna Therapeutics and Broken String Bioscien... — by email.

Frequently Asked Questions

Amarna Therapeutics — Next generation gene therapy | unlocking the potential & expanding the boundaries. Broken String Biosciences — Turning breaks into breakthroughs. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Amarna Therapeutics has raised $15.00M while Broken String Biosciences has raised $23.65M.
Amarna Therapeutics and Broken String Biosciences operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Amarna Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Amarna Therapeutics on 11 Sep 2024, and Broken String Biosciences on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes